3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Lymphoid
1
Conditions
Sjogren's Syndrome
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Interventions
Cytarabine
34
Cyclophosphamide
21
Vincristine
20
Methotrexate
18
Dexamethasone
18
Mercaptopurine
16
Idarubicin
16
nilotinib
15
Daunorubicin
15
Imatinib Mesylate
13
fludarabine
12
Granulocyte Colony-Stimulating Factor
12
Asparaginase
12
Rituximab
11
Doxorubicin
10
Prednisolone
9
Etoposide
8
Prednisone
7
Thioguanine
6
Teniposide
6
Mitoxantrone
6
Dasatinib
6
venetoclax
5
fludarabine phosphate
5
Vindesine
5
Stem Cell Transplantation
5
Ifosfamide
5
Azacitidine
4
posaconazole
3
pirtobrutinib
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 4
×
belimumab
×
Other hematologic neoplasm
×
Clear all
NCT06410833
2024-05-16
BRRPJS
Peking Union Medical College Hospital
Phase 4
Recruiting
15 enrolled